What sector does Epigral Limited belong to?

Epigral Limited operates in the Commodities sector, specifically the Specialty Chemicals industry, and is listed on the NSE.

What is the current share price of EPIGRAL?

As of the latest available quote, EPIGRAL traded at ₹1,131.10. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of EPIGRAL?

Epigral Limited has a price-to-earnings (P/E) ratio of about 18.02. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of EPIGRAL?

The market capitalisation of Epigral Limited is approximately ₹4,880 Cr.

Is Epigral Limited profitable?

For its latest reported financial year, Epigral Limited recorded a net profit margin of about 13.14%.

Does EPIGRAL pay a dividend?

Epigral Limited does not currently show a dividend yield in our data.

What is the return on equity (ROE) of EPIGRAL?

Epigral Limited has a return on equity (ROE) of about 16.00%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of EPIGRAL?

Over the past 52 weeks, EPIGRAL has traded between a low of ₹807.00 and a high of ₹1,808.80.

Epigral Limited

EPIGRAL NSE Commodities Specialty Chemicals

₹1,131.10

-1.63%

Delayed · cached 15 min

Fair value analysis

EPIGRAL

Epigral Limited

₹1,149.80

Close used for this calculation

₹1,669.20Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

73/100

Profitability21/25

Returns18/25

Balance Sheet19/25

Efficiency15/25

Growth20/25

Strong

Quality radar

Consensus fair value

₹1,669.20

Below FV

▲ +45.2% against the close used

Model range ₹233.84 – ₹3,465.50

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹233.84Fair value₹1,669.20Bull₹3,465.50

FairClose

52-week traded range

52W low ₹810.4552W high ₹1,798.70

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

Epigral Limited closed at ₹1,149.80, 31.1% below the consensus fair value of ₹1,669.20 drawn from 9 valuation models.

Financial DNA score 73/100 — Strong. P/E of 18.0x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹233.84

-79.7%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹860.26

-25.2%

√(22.5 × EPS × BVPS)

EPS=76.95, BVPS=427.43 · outside Graham range (P/E 18, P/B 2.7) — asset-light, treat as a rough floor

Graham Formula

₹3,465.50

+201.4%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=20%, FD=7%

P/E Fair Value

₹2,300.81

+100.1%

EPS × 29.9x (sector P/E)

EPS=76.95, Sector P/E=29.9x

Peter Lynch (PEG)

₹1,923.75

+67.3%

EPS × Growth% (PEG = 1 is fair)

EPS=76.95, g=25%

EV/EBITDA

₹2,978.17

+159.0%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=7.34B

Book Value (P/B)

₹1,068.59

-7.1%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=427.43, ROE=16%, g=6%, r=10%

Reverse DCF

₹1,149.80

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 3.2% | Historical: 25%

Margin of Safety

₹1,286.33

+11.9%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=1715.1, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer